HOME >> BIOLOGY >> NEWS
US clinical researchers resist full financial disclosure, according to Conflicts-of-Interest Study

Researchers and officials charged with the ethical oversight of research are often reluctant to fully disclose financial interests to potential clinical research participants, according to the latest Conflict-of-Interest Notification Study (COINS), just published in the Fall 2006 issue of the Journal of Law, Medicine and Ethics. Instead, those interviewed suggest a better approach for such disclosures would be to offer potential research participants a range of dollars or even use adjectives such as a "substantial investment" to describe the extent of a researcher's financial interest.

The study, a survey of attitudes, beliefs and practices among members of institutional review boards, conflict-of-interest committees and researchers, reveals a key reason for the reluctance among researchers to share the full dollar amount: the belief that because potential research subjects may lack the sophistication to put conflicts of interest in context, they may overestimate the influence of money on the researcher's behavior and possibly refuse to participate.

"The findings raise important questions about the informed consent process," said principal investigator Jeremy Sugarman, M.D., the Harvey M. Meyerhoff Professor of Bioethics and Medicine at The Berman Bioethics Institute at Johns Hopkins University. "Some researchers appear to believe that because disclosing any dollar amount could influence a person's decision of whether or not to participate in a clinical trial, the dollar amount shouldn't be revealed at all. Instead, the person should only be told that a financial interest exists, but there's widespread disagreement on how to do it. Should researchers name the source of their funds? Should the disclosure highlight potential consequences of the financial relationship? When and how should all of that be disclosed?"

The ongoing Conflict of Interest Notification Study (COINS) was initiated to establish a framework for developing po
'"/>

Contact: Ed Bodensiek
ebodensiek@jhu.edu
410-516-8523
Johns Hopkins University
8-Sep-2006


Page: 1 2 3

Related biology news :

1. Preclinical study links gene to brain aneurysm formation
2. Gene variant is associated with brain anatomy, clinical course of ADHD
3. New joint replacement material developed at MGH put to first clinical use
4. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
5. From clinical cancer research: rethinking therapeutic cancer vaccine trials
6. Manganese levels increase in scrapie-infected sheep before clinical symptoms develop
7. Biovest announces interim blinded data of fast-tracked pivotal Phase 3 clinical trial of BiovaxID
8. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
9. UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus
10. BDSI announces positive phase III clinical trial results
11. Oncolytics Biotech Inc. proceeds to initiate US Phase II sarcoma clinical trial

Post Your Comments:
(Date:5/16/2013)... Bethesda, MD FASEB MARC (Maximizing Access to ... recipients for The Society for Developmental Biology (SDB) ... 16-20, 2013. These awards are meant to promote ... underrepresented groups into the mainstream of the basic ... young scientists at the SDB 2013 Annual Meeting. ...
(Date:5/16/2013)... lining the body,s blood vessels, is extremely resilient. ... this super-tenuous structure routinely withstands blood flow, hydrostatic ... unique and highly dynamic barrier that maintains the ... circulatory system. , It,s also extremely adaptable. In ... to enable immune cells to reach various ...
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
Breaking Biology News(10 mins):Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3
(Date:5/17/2013)... 17, 2013 Rust removal is one of ... home items could be damaged. To help rust contractors make ... its no-scrubbing rust remover it called Rusterizer. It ... with 10% discount. , My Cleaning Products explained that rust ... or by staining them. The first one, it said, ...
(Date:5/16/2013)... Tampa, FL (PRWEB) May 16, 2013 ... has named Barbara A. Myers, CAE, to the ... Development. In her new role, Myers will be ... event development and production strategies, advancing the Society’s ... development processes and continuing to refine organizational, membership ...
(Date:5/16/2013)... Mass. (PRWEB) May 16, 2013 Cambridge ... Summit from August 19-23, 2013 at the Renaissance Waterfront ... the Summit provide a close-up look at the current ... and ensuring bottom-line quality. Leaders in the field ... ways to produce biopharmaceuticals with greater specificity and efficiency. ...
(Date:5/16/2013)... HAYWARD, Calif. , May 16, 2013 ... University, Beijing , and the ... www.magceutics.com ) have demonstrated a novel therapy for reversing ... brain magnesium levels, they find significant cognitive improvement in ... to demonstrate a mechanism for reversing cognitive decline for ...
Breaking Biology Technology:Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount 2ISPE Names Barbara A. Myers, CAE, as Vice President of Professional Development 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 2Elevation of Brain Magnesium Reverses Memory Deficits in Alzheimer Mice 3
Cached News: